DOR BIOPHARMA INC — Form D

DOR BIOPHARMA INC of EWING, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2009-03-24. The offering totals $400K, of which $300K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Cyrille F BuhrmanDirectorEwing, NJ
James S KuoDirectorEwing, NJ
Greg A LapointeDirectorEwing, NJ
Evan MyrianthopoulosDirectorEwing, NJ
Christopher J SchaberDirectorEwing, NJ
Robert N BreyExecutive OfficerEwing, NJ
James ClavijoExecutive OfficerMiami, FL
Brian HamiltonExecutive OfficerRichmond, VA
Evan MyrianthopoulosExecutive OfficerEwing, NJ
Christopher J SchaberExecutive OfficerEwing, NJ
Jerome B Zeldis, M.D., Ph.D.DirectorSouth Plainfield, NJ
Adam T RumageExecutive OfficerPrinceton, NJ
Richard C Straube, MD MScExecutive OfficerPrinceton, NJ
Karen Christopher KrumeichExecutive OfficerPrinceton, NJ
Oreola Christopher Donini, PhDExecutive OfficerPrinceton, NJ
Keith L Brownlie, CPADirectorPrinceton, NJ
Jerome B Zeldis, PhDDirectorPrinceton, NJ
Gregg A LaPointe, CPADirectorPrinceton, NJ
Robert J Rubin, MDDirectorPrinceton, NJ
R. Christopher Cavalli, PhDExecutive OfficerPrinceton, NJ
Marco M Brughera, DVMDirectorPrinceton, NJ
Christopher J Schaber, PhDDirectorPrinceton, NJ
Christopher J Schaber, PhDExecutive OfficerPrinceton, NJ
Christopher J Schaber, Ph.D.DirectorPrinceton, NJ
Christopher J Schaber, Ph.D.Executive OfficerPrinceton, NJ

Other filings by this issuer (6)

FiledFormOfferingSold
2017-11-08D$2.0M$2.0M
2013-05-03D$1.5M$1.5M
2010-07-02D$5.9M$5.9M
2009-02-27D$4.5M$4.5M
2009-02-03D$2.4M$2.4M
2008-12-05D$1.5M$1.5M

More